Psychosocial Impacts of Radiation Tattooing for Breast Cancer Patients: A Critical Review by Clow, Barbara & Allen, Janet













The emotional and psychological trauma and distress 
of breast cancer diagnosis, treatment, and recovery are 
well-documented. The existing literature attributes this 
distress to fears about death, recurrence and overall health 
(Ashing-Giwa et al.), the impact of treatment and recov-
ery on relationships, children or work (Ashing-Giwa et 
al.; Buick et al.), and concerns about physical changes 
to the breasts resulting from mastectomy, lumpectomy, 
and other treatments (Deshields et al.). Other studies 
explore possible associations between breast cancer diag-
nosis and treatment and mental health issues, including 
post-traumatic stress symptoms (ptss) (Andersen et al.; 
Andrykowski and Cordova) and depression (Mosher and 
Danoff-Burg; Roussi et al.). What is unclear from this 
research, however, is how the use of permanent tattoos 
in radiotherapy for breast cancer affects women’s psy-
chosocial understandings and experiences of the disease. 
Even research that focuses on patients’ experiences of 
radiotherapy does not directly address the psychological 
impact of permanent radiation tattooing (Buick et al.; 
Deshields et al.; Siekkinen et al.).
The current standard of practice for defining the area 
to be irradiated for breast cancer treatment is by marking 
the skin with small, permanent blue ink dots or “tattoos” 
(Griffiths et al.; Winer et al.). For breast cancer patients, 
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tattooing typically involves anywhere from four to twelve 
dots—depending on the institution—at points ranging 
from the collarbone to the fold under the breast and from 
the breastbone to underneath the underarm (Karmarnicky, 
Rosenberg, and Betancourt). While health care provid-
ers stress the need for tattoos to ensure accuracy and as a 
permanent record of radiation exposure, a growing body 
of research and anecdotal evidence points to an interest 
in alternatives to and removal of permanent medical tat-
toos used in radiotherapy (Foreman; Probst et al.). This 
interest seems particularly high among breast cancer pa-
tients, which supports the conclusion that some women 
experience distress in response to this treatment practice 
(Alam and Arndt; Billingsley; David, Castle and Mossi; 
Foreman).
 This discussion is based on an analysis of traditional 
peer-reviewed literature and grey literature, defined 
as information produced by government, academics, 
business, industry and the public in both electronic 
and print formats but which is not controlled by com-
mercial publishing (Schoepel and Darace). Web-based 
information, particularly patient/survivor fora and 
blogs, represents an important source of evidence for 
this analysis. Our review of literature reveals that women 
have diverse responses to medical tatooing for radiation 
treatment, positive and negative, which may affect their 
experiences of cancer and care. Yet limited attention is 
afforded this aspect of cancer treatment, particularly in 
the peer-reviewed literature. 
At the same time, a small body of research suggests that 
women’s experiences of medical tattooing may be affected 
by social location—race, culture, socio-economic status, 
geography, etc. Discussion of the social determinants 
of health is also generally absent in the peer-reviewed 
literature. This dearth of systematic research on cancer 
tattooing is disturbing in light of the varied perceptions 
and experiences of women living with a diagnosis of 
breast cancer. 
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Theoretical Framework
Women’s voices are all but absent in the literature that ad-
dresses radiation tattooing used in breast cancer treatment. 
Because a feminist framework positions lived experience as 
a valid source of knowledge (Reinharz and Davidman), it is 
an important lens through which to view the psychosocial 
aspects of radiation treatment for breast cancer. Patients’ 
concerns are evident, not so much in formal research, but 
through anecdotal evidence. For example, online personal 
weblog or “blog” entries and discussion groups that address 
the issue provide a snapshot of attitudes about permanent 
radiation tattoos. Inclusion of these informal sources of 
information is not intended to replace evidence obtained 
through systematic, peer-reviewed research, but simply to 
provide a preliminary starting point for discussions about 
how radiation tattooing is currently being defined—or not 
defined—as a challenge for breast cancer patients. Clearly, 
further research is needed to explore the themes raised in 
this review of the literature from a feminist perspective 
that accounts for women’s experiential knowing.
It is understandable that both aesthetics and emotional 
significance factor into women’s medical decision-making 
about their breasts considering the complex, and often 
contradictory, meanings of women’s breasts in modern 
Western culture. Rachel Millsted and Hannah Frith state 
that “women’s breasts are invested with social, cultural 
and political meanings which shape the ways in which 
we make sense of and experience our embodied selves” 
(455). They are simultaneously sites of maternal nurtur-
ing, femininity, and sexual desirability (Jones; Millsted 
and Frith; Young). Early representations of the female 
breast in art and mythology valued voluptuous, prominent 
breasts as symbols of abundance, fertility, and nurturance 
(Jones). Standards of beauty shifted in the middle-ages 
in Europe to a preference for small, round, firm, and 
widely-spaced breasts and their role in male sexual pleasure 
and desire overshadowed any maternal meaning (Jones). 
With colonization came nude images of African women 
in photographs and art in nineteenth century Europe and 
these images clearly depicted African women’s bodies and 
breasts as sagging and used-up—in stark visual contrast to 
the perky, eroticized, white aesthetic ideal (Jones). 
The commercial potential of women’s breasts was first 
realized during World War ii when “filmmakers and 
advertisers realized that if the prominent-breasted female 
type could sell the war, then it might also promote other 
products and services” (Jones 17). With this commodi-
fication process firmly entrenched in mainstream media 
and entertainment, women come to see their breasts as 
objects for others rather than an aspect of their embodied 
selves (Jones; Millsted and Frith; Young). Currently, there 
is only one “perfect” breast shape—one that is “round, 
positioned high on the chest, large and firm” (Jones 18). 
While these cultural influences exert pressure on women 
to conform to this ideal, it does not mean that women 
are merely passive vessels for culturally prescribed norms 
regarding the “perfect” breast: “women actively negotiate 
their position in relation to a complex web of discourses, 




The role of permanent radiation tattooing in breast cancer 
treatment is neglected in the literature, in part because 
the marks are sometimes seen—by both patients and 
practitioners—as a relatively minor issue in the context 
of managing a disease that is potentially life threatening 
(Alam and Arndt; Harris). In support of this view, some 
women living with permanent radiation marks have re-
ported ready acceptance of the tattoos while others view 
them as a minor nuisance or inconvenience (Foreman). 
However, there is also evidence to suggest that permanent 
radiation tattoos pose a significant psychosocial challenge 
for some women living with breast cancer. For instance, 
many of those reporting distress see the tattoos as com-
pounding the trials of dealing with significant physical 
changes to their breasts and bodies arising from diagnosis 
and treatment (Langellier). Clearly, women experience a 
wide range of reactions to radiation tattooing for breast 
cancer and the depth of their reactions as well as the 
reasons for them vary.
Breast cancer patients may also object to tattoos for 
cultural and/or religious reasons. One example of this 
potential conflict involves women who observe Orthodox 
Judaism because tattooing is explicitly forbidden by the 
Torah. A website dedicated to Jewish women’s health 
advises readers that temporary markings should be used if 
at all possible and if not, that the tattooing should be per-
formed by a non-Jew (Jewish Women’s Health). Similarly, 
Langellier documents a case in which a devout Catholic 
Permanent radiation tattoos pose a significant psychosocial challenge for 
some women living with breast cancer. Many of those reporting distress see 
the tattoos as compounding the trials of dealing with significant physical 
changes to their breasts and bodies arising from diagnosis and treatment.
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breast cancer patient—who understood tattooing to be 
inconsistent with her faith—expressed fears associated 
with tattooing. “So a religious thing,” she said, “would be 
that I had to get over the fact of I had four little dots of 
tattoo and when I grew up the thing is that people who 
had marked their bodies were children of the devil and 
that you were to go to Hell” (Langellier 153). Anecdotal 
evidence suggests that the religious or cultural significance 
of tattooing may not be validated by medical professionals. 
For example, an online blog entry describes a woman’s 
experience in which she raised a religious objection to the 
use of permanent tattoos but was told by the doctors and 
technicians that she had to have them (Eva). As mentioned 
earlier, medical tattoos are regarded as the gold standard 
for marking the field of radiation treatment, but there is 
evidence that alternatives to tatoos, semi-permanent or 
temporary marks using henna and other products, have 
been offered by medical professionals when religious 
objections are raised (Gitlin). Further research is needed 
that considers the role of faith and culture in patients’ 
meaning-making and decision-making processes about 
this treatment practice and the potential inconsistencies 
in provision of care.
While much of the evidence found from a search of 
online support forums suggests that women’s experiences 
with permanent radiation tattooing are largely negative, 
it is possible that these views do not reflect the majority 
of women, given that those who are most dissatisfied 
with their experiences are more likely to voice their 
concerns. Certainly other evidence suggests a signifi-
cantly different interpretation of tattooing. For some 
breast cancer patients, the blue dots themselves come to 
represent bonding and sisterhood—they are perceived as 
badges of honour for having survived the disease. One 
example of defining the permanent tattoos in this way 
is Schwan’s book, The	Blue	Tattoo	Club:	A	Breast	Cancer	
Sisterhood. The book—and associated online support 
forum—consists of personal stories from breast cancer 
survivors about diagnosis, treatment, and recovery. The 
blue tattoos indicate membership in this club, member-
ship that women do not choose but which nevertheless 
connects them in their healing struggles and victories. 
Sheryl Crow, a prominent music artist and member of 
the blue tattoo club has been quoted as saying, “I’ve kept 
my tattoo because it is a reminder for me. It’s a reminder 
of that time. It’s a reminder of how I want to look at my 
life. I want to remember” (Entenmann).
Similarly, some women seem to embrace tattooing after 
treatment as an opportunity for self-expression. While 
much of the support for breast cancer survivors focuses 
on aesthetic aspects of healing such as breast recon-
struction, nipple and areolar tattooing, and prosthetics 
(See El-Ali, Dalal and Kat; Hang-Fu and Snyderman; 
Henseler et al.; Spear and Arias), some survivors are 
eschewing efforts to match their pre-treatment appear-
ance in favour of expressing the nuances of their cancer 
experiences and consequent shifts in personal identity 
through non-medical tattooing. A growing number of 
breast cancer survivors are actively transforming their 
medical tattoos and scars into works of art by incor-
porating them into permanent decorative designs that 
have personal significance. Women are redefining their 
experiences of breast cancer by becoming walking works 
of art and redefining the meaning of “disease” and “ill-
ness” in the process (Radley and Bell). Radley and Bell 
maintain that the creation of visual images depicting 
breast cancer increases the visibility of the disease thereby 
challenging the “cultural cloak that has lain over both 
cancer generally and breast cancer in particular” (368). 
Such forms of artistic expression can also represent a 
type of personal narrative—a way for survivors to share 
a “story of	the body through	the body” (Langellier 146). 
For many women, cancer has meant a loss of control 
(Thomas-MacLean) and the act of redefining the marks 
and/or scars associated with cancer treatment constitutes 
an act of re-embodiment and empowerment.
Once the body is permanently marked for treatment, 
some women choose re-marking on their own terms as 
a form of resistance and an act of reclaiming their bod-
ies (Langellier). This act of resistance is consistent with 
feminist critiques of how the medical establishment views 
patient autonomy, which is currently defined largely in 
terms of rational choice and informed consent (Dodds). 
According to feminist theories of bioethics, this under-
standing of autonomy is limited as it fails to account 
for the social circumstances and power relations that 
shape the context in which the choice is made (Dodds). 
Autonomy is also conceived of as an all-or-nothing 
proposition—either one is deemed competent to give 
informed consent or not. According to Dodds, “this lack 
of middle ground, of an awareness that the capacity to 
make health care decisions may admit by degrees, is one 
effect of the identification of autonomy with informed 
consent, which can be particularly harmful to women’s 
interests” (217). She notes that a patriarchal system, the 
kinds of medical decisions women are required to make, 
and the cultural perception of women as irrational and 
overly emotional all contribute to the construction of 
health care options that limit women’s autonomy (Dodds). 
While informed consent and the capacity to choose are 
of course important, Dodds argues that “respect for au-
tonomy is not restricted to respect for choices of a certain 
kind but also requires the development of autonomous 
selves” (226-7). 
A review of online support forums and personal blog 
narratives also suggests that many breast cancer patients 
feel they have little or no choice about permanent tattoos. 
BrandonMom stated: 
Whether you are someone that enjoys seeing your 
battle scars, or someone that prefer [sic] to minimize 
the permanent marks, the choice should be yours 
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and you should be informed of the pros/cons of 
each method [temporary or permanent marks]. Not 
just told “you will get tattoos.” From most women I 
have spoken to, they are not aware there is another 
choice. That seems wrong to me. The choice should 
be the patient’s to make, as the patient has to live 
with the decision. 
This perceived lack of autonomy is highly prob-
lematic given the wealth of research that confirms the 
psychological benefit of women’s active involvement in 
a previous study on cancer support services in Atlantic 
Canada showed that women made treatment choices based 
on social rather than medical imperatives. Faced with the 
choice of a mastectomy or extended absences from home 
to have radiation treament following a lumpectomy, many 
women opted for the more invasive surgery because it 
allowed them to remain with their families and friends 
(Clow et al.). We not only need more research on women’s 
choices in relation to breast cancer tattooing, but also 
research that addresses the impact of social location on 
women’s choices.    
treatment (Deadman et al.; Fallowfield et al.; Pozo et 
al.; Till, Sutherland, and Meslin). While some sources 
identify the patient’s right to choose between temporary 
or permanent tattoos (Probst et al.; “Use of Tattoos”), 
often this information is presented to emphasize the 
inferiority of temporary marks. Opportunities for choice 
regarding treatment are particularly significant for women 
marginalized by socioeconomic status. For example, 
Clark notes that working class women with breast cancer 
are less likely to advocate for themselves or challenge 
physicians’ recommendations than middle-class women 
who have greater access to resources and information. 
As permanent marks are considered standard practice, 
little is known about women’s preferences, resistance, or 
autonomy in this regard.
It is important to note that choice can be a problematic 
element for female breast cancer patients. Thomas-Ma-
cLean notes that women may struggle with making breast 
cancer treatment decisions and be uncomfortable as well 
as unfamiliar with the autonomy afforded them in this 
regard. She identifies the important dilemma that “given 
the uncertainty of many cancer treatments, one must 
ask what choices are really being presented” (Thomas-
MacLean 634). A feminist analysis of this phenomenon 
suggests that women, in contrast to men, often lack a 
frame of reference for egalitarian approaches to health 
care.  Without experience being treated as respected 
partners in health care, women may be unaccustomed to 
assuming a proactive stance on their own behalf (Thomas-
MacLean). Of course this analysis is not meant to imply 
that women are incapable of exercising autonomy, but 
rather that gender—the behaviours, roles, attitudes and 
expectations attributed to women and men by society on 
a differential basis—will affect how women understand 
and exercise “choice” (Clow et al. 2009). For example, 
Medical Standards
The medical justifications for using any kind of tattoos 
to define the radiation field are precision and consistency 
(David, Castle, and Mossi; Harris; “Use of Tattoos”; 
Uyeda). Typically, radiation treatment is administered in 
a series of daily consecutive doses over a period of several 
weeks and it is crucial that these doses are applied to the 
exact same area each time (David, Castle, and Mossi). 
Another frequent argument for permanent tattoos, as 
opposed to temporary markings, is based on the need 
for long-term consistency: should additional radiation 
be required—due to cancer recurrence or the develop-
ment of a new cancer—it is critical to know the exact 
site of treatment because the tissue cannot withstand a 
second full-dose course of radiation treatment (Kraus-
Tiefenbacher et al.). Physicians often discourage patients 
from having tattoos removed on these grounds, arguing 
that the marks aid in follow-up examinations and serve 
to identify the irradiated area should the cancer re-occur 
and further radiation is needed (Hampshire; Harris; “Use 
of Tattoos”). According to some researchers, marks in the 
centre of the torso are most important years later should a 
breast cancer patient require future radiation treatment to 
an adjacent area (Probst et al.) or access additional treat-
ment at a different facility (“Use of Tattoos”). 
While the medical rationale for permanent tattooing 
has been clearly articulated, David, Castle, and Mossi 
have identified three main concerns about the practice 
and its medical justification: mobility, visibility, and 
emotional impact on the patient. First, mobility refers to 
the tendency of marks to shift over time. In other words, 
permanent tattoos do not necessarily provide an accurate 
record of radiation treatment because their location can 
change over time, particularly for overweight and elderly 
Some women choose re-marking on their own terms as a form of resistance 
and an act of reclaiming their bodies. This act of resistance is consistent 
with feminist critiques of how the medical establishment views patient 
autonomy, defined largely in terms of rational choice and informed consent.
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patients, due to stretching or shrinking of the skin and 
changes in elasticity (David, Castle, and Mossi; Probst 
et al.). Second, visibility concerns include locating and 
identifying the dots on darker-skinned patients and dis-
tinguishing the radiation marks from hair follicles. While 
educational materials often emphasize the smallness of 
radiation tattoos, the size itself can create challenges for 
accurately locating the marks from one treatment to the 
next. Moreover, it is sometimes necessary to use temporary 
markings because the permanent ones are not universally 
effective for all breast cancer patients. For instance, stan-
dard blue-ink tattoos may not show up well on patients 
with darker skin tones (David, Castle, and Mossi), which 
suggests the ineffectiveness of using permanent tattoos 
for treating African Canadian women and other women 
of colour with breast cancer. Third, emotional impact 
refers to the fact that “permanent tattoos remind cancer 
survivors daily of their disease and treatment” (David, 
Castle, and Mossi 1), experiences that many patients may 
prefer to forget. 
Growing recognition of the potential psychological 
meanings attached to permanent marks has led some 
researchers to explore techniques for temporarily out-
lining the radiation area. For instance, David, Castle, 
and Mossi proposed the use of invisible fluorescent ink 
that is black light reactive, however, their study was not 
conducted on patients and further research is needed 
to assess the viability of this option. Alternatives such 
as semi-permanent or temporary markings made using 
markers or surgical pens have been shown to be equally 
effective as permanent markings (Probst et al.). Probst et al. 
conducted randomized trials with early stage breast cancer 
patients comparing the effectiveness of a combination of 
semi-permanent and permanent markings with the use 
of semi-permanent markings alone and found no signifi-
cant difference between the two groups. They concluded 
that, for the majority of patients, “the choice not to have 
permanent tattoos will not interfere with the accuracy of 
the treatment application” (Probst et al. 188). 
A review of breast cancer information and education 
websites demonstrates that information about permanent 
and semi-permanent or temporary markings is available, 
but there is little guidance about when or why different 
types of markings should be used. Despite the generally 
agreed upon standards of radiation tattooing for breast 
cancer patients, practices differ from country to coun-
try and even between jurisdictions and institutions. It 
is also interesting to note that standards are changing, 
although it is often not clear how or why these changes 
to policy and practice are being made. For instance, the 
Nova Scotia Cancer Centre (nscc) in Halifax specifies 
using four to six permanent markings “about the size 
of the tip of a pen” located on the chest or breast area. 
Recently, nscc reviewed its marking practices for breast 
cancer radiation treatment and determined that the mark 
on the upper breast bone—the most visible mark—was 
not critical and it has since been eliminated. Because 
temporary marks are time consuming—they take longer 
to apply and need to be refreshed—it may be impracti-
cal for treatment facilities with high patient volume to 
consider options other than permanent marks. But more 
research is needed to understand why some health systems 
or centres regard permanent markings as the standard of 
care while others do not, particularly in light of patient 
reactions to tattoos.
Conclusion
This review highlights gaps in the literature about the use 
of permanent tattoos to specify the radiation treatment 
area for breast cancer patients and the meanings this 
treatment practice may have for the women affected. We 
are also ill-informed as to the possible significance the 
tattoos may have in the ways women construct meaning 
and establish community around their experience of breast 
cancer treatment and recovery. Meaning-making and sup-
port-building are part of the multi-layered emotional and 
psychosocial processes of managing disease experiences, 
including the various aspects of cancer diagnosis and 
treatment. Furthermore, formal research on breast cancer 
patients’ autonomy in medical decision-making respecting 
the use of permanent tattoos should be undertaken using 
feminist and sex- and gender-based lenses. Currently, there 
is no comprehensive analysis of the potential psychosocial 
impacts of using permanent tattoos to specify the radiation 
area for breast cancer patients. 
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Take me back to white curtains
blowing in a fresh wind —
a Flower Power poster
with coils of snakes around its head.
Autumn leaves hang brown now on 
branches,
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